Manufacture of basic pharmaceutical products and pharmaceutical preparations
579 Belgian companies whose main activity falls under NACE code 21 have filed annual accounts. Their median solvency is 47.8% for financial year 2024.
Sector medians
Computed by IdonisDistribution across the sector's companies for financial year 2024: a quarter of companies sit below the 1st quartile, half below the median, three quarters below the 3rd quartile.
| Indicator | 1st quartile | Median | 3rd quartile | Companies |
|---|---|---|---|---|
| Solvency | 16.5% | 47.8% | 77.0% | 495 |
| Current ratio | 0.39 | 1.23 | 3.43 | 477 |
| ROE | -2.6% | 4.6% | 22.5% | 409 |
| Equity | 19,709 € | 243,242 € | €1.37m | 509 |
| Total assets | 186,131 € | 654,594 € | €2.96m | 506 |
| Net result | −13,873 € | 3,720 € | 80,707 € | 509 |
| Headcount (avg FTE) | 1.8 | 10.4 | 57.1 | 174 |
Medians computed by Idonis from annual accounts filed with the National Bank, all sizes combined. The same panel is the sector benchmark on every company page. Method
Largest companies: Manufacture of basic pharmaceutical products and pharmaceutical preparations
Ranked by total assets in the latest filed accounts. This is a size criterion, not an assessment.
| # | Company | Total assets | Revenue | Equity | FTE | Year |
|---|---|---|---|---|---|---|
| 1 | Janssen Pharmaceutica 2340 Beerse | €21.6bn | €21.8bn | €11.7bn | 5,324.5 | 2025 |
| 2 | UCB Pharma 1070 Anderlecht | €20.7bn | €4.62bn | €16.2bn | 1,960.6 | 2025 |
| 3 | GlaxoSmithKline Biologicals 1330 Rixensart | €17.8bn | €7.44bn | €9.98bn | 8,371.0 | 2025 |
| 4 | UCB Biopharma 1070 Anderlecht | €7.15bn | €2.04bn | €1.18bn | 1,395.2 | 2025 |
| 5 | Pfizer Manufacturing Belgium 2870 Puurs-Sint-Amands | €2.46bn | €1.02bn | €1.89bn | 4,020.8 | 2025 |
| 6 | Genzyme Flanders 2440 Geel | €1.00bn | €457.2m | €862.1m | 990.1 | 2025 |
| 7 | Baxalta Belgium Manufacturing 7860 Lessines | €713.1m | €374.2m | €560.0m | 1,196.8 | 2026 |
| 8 | Ajinomoto Omnichem 9230 Wetteren | €476.3m | €468.2m | €323.9m | 863.4 | 2026 |
| 9 | Telix Innovations 4040 Herstal | €473.4m | €243.8m | €116.7m | 19.8 | 2025 |
| 10 | Pfizer 1050 Ixelles | €377.4m | €358.3m | €129.1m | 297.0 | 2025 |
| 11 | Organon Heist 2220 Heist-op-den-Berg | €349.6m | €287.4m | €235.2m | 1,004.9 | 2025 |
| 12 | PolyPeptide 1420 Braine-l'Alleud | €331.7m | €156.1m | €103.8m | 485.0 | 2025 |
| 13 | Novartis Manufacturing 2870 Puurs-Sint-Amands | €285.2m | €256.5m | €148.4m | 980.0 | 2025 |
| 14 | Vision Healthcare 8560 Wevelgem | €283.8m | €14.3m | €153.7m | — | 2025 |
| 15 | Laboratoires S.M.B. 1080 Molenbeek-Saint-Jean | €261.5m | €112.5m | €172.9m | 40.0 | 2025 |
| 16 | Physiol 4031 Liège | €245.1m | €66.4m | €78.4m | 159.1 | 2025 |
| 17 | PHOENIX Pharma Belgium 1200 Woluwe-Saint-Lambert | €235.4m | €1.33bn | €46.5m | 496.7 | 2026 |
| 18 | Univercells 6040 Charleroi | €231.6m | — | €142.8m | 83.6 | 2023 |
| 19 | Roche 1070 Anderlecht | €164.7m | €448.8m | €64.5m | 122.7 | 2025 |
| 20 | Baxter 7860 Lessines | €160.0m | €106.6m | €83.8m | 901.3 | 2025 |
“—”: not published. Small companies (micro and abridged accounts) do not have to publish their revenue.
Where are they based?
Municipalities with the most
Manufacture of basic pharmaceutical products and pharmaceutical preparations: rankings by region and province
The largest companies in the sector in each region and province, by municipality of the registered office. A ranking is published once 10 companies in the sector publish the figure there.
| Area | Total assets | Revenue | Headcount |
|---|---|---|---|
| Flanders | Largest | Revenue | Employers |
| Wallonia | Largest | Revenue | Employers |
| Brussels | Largest | Revenue | Employers |
| Antwerp province | Largest | Revenue | Employers |
| Flemish Brabant | Largest | — | — |
| Limburg | Largest | — | Employers |
| East Flanders | Largest | — | Employers |
| West Flanders | Largest | — | — |
| Walloon Brabant | Largest | Revenue | Employers |
| Hainaut | Largest | Revenue | Employers |
| Liège province | Largest | Revenue | Employers |
| Namur province | Largest | — | — |
Sub-sectors
Frequently asked questions
How many Manufacture of basic pharmaceutical products and pharmaceutical preparations companies are there in Belgium?
579 Belgian companies whose main activity falls under NACE code 21 (Manufacture of basic pharmaceutical products and pharmaceutical preparations) have filed annual accounts with the National Bank.
What is the median solvency in Manufacture of basic pharmaceutical products and pharmaceutical preparations?
For financial year 2024, median solvency (equity over total assets) is 47.8%. The middle half of companies lies between 16.5% and 77.0% (495 companies).
What is the largest company in Manufacture of basic pharmaceutical products and pharmaceutical preparations?
By total assets, it is Janssen Pharmaceutica (€21.6bn, financial year 2025).
Where are Manufacture of basic pharmaceutical products and pharmaceutical preparations companies based?
The municipalities with the most: Liège (21), Anderlecht (15), Ghent (11).
Analyse companies in Manufacture of basic pharmaceutical products and pharmaceutical preparations
Filter these companies by size, soundness and trend, follow them and get an alert when their accounts or publications change.
Open the full file →Active companies (legal entities) that have filed at least one set of annual accounts, based on the Crossroads Bank for Enterprises and the National Bank of Belgium. The sector is the main activity in the register; the municipality is that of the registered office. Data updated on 12 Nov 2026.